MHT Plus Semaglutide Tied to Greater Weight Loss in Menopause Study
A non-peer-reviewed analysis of about 2,400 women over 45 links menopausal hormone therapy plus semaglutide to greater sustained weight loss, while tirzepatide results fell short of significance.